Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modulation of inhibitory control networks relate to clinical response following ketamine therapy in major depression

Translational Psychiatry(2020)10.1038/s41398-020-00947-7Source: DataRank Database

Modulation of inhibitory control networks relate to clinical response following ketamine therapy in major depression is a research paper published in Translational Psychiatry (2020). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (45)IDs (PubMed)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Joana Loureiro ORCID,Megha Vasavada,Antoni Kubicki ORCID,Benjamin Wade ORCID,Shantanu H. Joshi ORCID

Live enrichment

PubMed:32732915

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health

Grant: MH110008

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health

Grant: MH102743

National Institutes of Health

Grant: 5U01MH110008-03

Perturbation of the treatment resistant depression connectome by fast-acting therapies

National Institutes of Health

Grant: 5K24MH102743-04

Biomarkers of fast acting therapies in major depression

NIMH NIH HHS

Grant: K24 MH102743

NIMH NIH HHS

Grant: U01 MH110008

goldLicense: cc-by

publisherhttps://www.nature.com/articles/s41398-020-00947-7.pdf

publisherhttps://www.nature.com/articles/s41398-020-00947-7

repositoryhttps://escholarship.org/content/qt86s2m1kk/qt86s2m1kk.pdf?t=qfk26u

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7393172

https://doi.org/10.1038/s41398-020-00947-7

Fields of Study

03 medical and health sciences0302 clinical medicineAdultAntidepressive AgentsDepressionMajor Depressive DisorderDepressive Disorder, Treatment-ResistantFemaleHumansKetamine

MeSH Terms

AdultAntidepressive AgentsDepressionMajor Depressive DisorderDepressive Disorder, Treatment-ResistantFemaleHumansKetamine

Keywords

AdultMajor Depressive DisorderBiological PsychologyClinical Sciences610ArticleDepressive Disorder, Treatment-ResistantClinical ResearchPsychologyHumansDepressive DisorderBiomedical and Clinical SciencesDepressionTreatment-ResistantNeurosciencesEvaluation of treatments and therapeutic interventionsMajor600Pharmacology and Pharmaceutical SciencesAntidepressive AgentsBrain DisordersMental Health6.1 PharmaceuticalsNeurologicalPublic Health and Health ServicesFemaleKetamine

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good health